======= MFNG ======= == Gene Information == * **Official Symbol**: MFNG * **Official Name**: MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4242|4242]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00587|O00587]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MFNG&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MFNG|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602577|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Glycosyltransferase that initiates the elongation of O- linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules (PubMed:10935626). Modulates NOTCH1 activity by modifying O-fucose residues at specific EGF-like domains resulting in inhibition of NOTCH1 activation by JAG1 and enhancement of NOTCH1 activation by DLL1 via an increase in its binding to DLL1 (By similarity). {ECO:0000250|UniProtKB:O09008, ECO:0000269|PubMed:10935626}. |Fringe| |O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity| |protein O-linked fucosylation| |marginal zone B cell differentiation| |mature B cell differentiation involved in immune response| |fucosylation| |acetylglucosaminyltransferase activity| |mature B cell differentiation| |blastocyst formation| |B cell activation involved in immune response| |positive regulation of Notch signaling pathway| |integral component of Golgi membrane| |positive regulation of protein binding| |blastocyst development| |regulation of Notch signaling pathway| |B cell differentiation| |protein O-linked glycosylation| |lymphocyte activation involved in immune response| |B cell activation| |positive regulation of binding| |regulation of protein binding| |lymphocyte differentiation| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |glycoprotein biosynthetic process| |leukocyte differentiation| |in utero embryonic development| |regulation of binding| |lymphocyte activation| |glycoprotein metabolic process| |pattern specification process| |hemopoiesis| |hematopoietic or lymphoid organ development| |carbohydrate derivative biosynthetic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |chordate embryonic development| |immune system development| |embryo development ending in birth or egg hatching| |anatomical structure formation involved in morphogenesis| |leukocyte activation| |embryo development| |carbohydrate derivative metabolic process| |cell activation| |immune effector process| |organonitrogen compound biosynthetic process| |extracellular space| |positive regulation of signal transduction| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |positive regulation of molecular function| |positive regulation of cell communication| |positive regulation of signaling| |immune response| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13199 * **Expression level (log2 read counts)**: 6.49 {{:chemogenomics:nalm6 dist.png?nolink |}}